My Shopping Cart
 
There are no items in your shopping cart.


The Cannabidiol (CBD) Conundrum: Understanding the Ingredient's Legal and Regulatory Status (CPG387R)

Presented by: Will Woodlee
 
Request Replay Date:
(*) Single User Price. For multiple users please call 1-800-223-8720
Pre Recorded Webinar
60 minutes
  •  Tue, April 10, 2018
Event Description
See the sneak peek before you buy!
 

Learn to Evaluate And Mitigate the Risks Presented by CBD Business Opportunities

Cannabidiol (CBD) has captured the attention of consumers and industry – and why not, CBD is found in products as diverse as cosmetics, dietary supplements, pet treats, vape pens, and investigational pharmaceuticals. Manufacturers, marketers, retailers, and consumers have shown increased interest in products containing CBD.  However, much confusion remains about the federal legal and regulatory status of the ingredient, potential sources, and the various types of products in which companies include the ingredient.

Derived from cannabis, CBD has also generated equal amounts of controversy and confusion. Chief among stakeholders’ concerns is the ingredient’s status under federal law. Federal regulators have staked out their positions, and industry groups have established their own. 

This session by expert speaker Will Woodlee will frame the issues in plain language, helping you understand the merits and vulnerabilities of these competing positions, the factors that matter in determining the status of a particular CBD-containing product, and the issues that remain unsettled.

The session will also focus on explaining the key legal positions taken by the Food and Drug Administration and the Drug Enforcement Administration and their implications for the CBD market. You will be better informed to navigate the complex federal rules that determine the legal and regulatory status of CBD and various CBD-containing products.  You will be better able to evaluate and mitigate the risks presented by certain CBD business opportunities.  You will get risk-mitigation strategies for operating in the CBD industry, and understand the legal questions that remain unanswered and require continued monitoring.You will also gain the background needed to monitor and contextualize new developments in federal law, regulation, and policy impacting the CBD market.

Session Objectives

In this session, you will learn:

  • What cannabidiol is
  • If CBD “marijuana” is subject to DEA enforcement
  • What “industrial hemp” and the Farm Bill are and what they mean for potential marketers of CBD products
  • Whether the FDA regulates CBD too, and what restrictions and requirements might apply, and whether the product type matters
  • Whether the status of a CBD product under state law matters

Who Should Attend

  • Employees of manufacturers, distributors, and retailers of CBD products
  • Attorneys
  • Regulatory affairs specialists
  • Marketing professionals serving the industry
  • Investors
  • Entrepreneurs
  • Scientists
  • Government employees interested in learning more about regulation of the category
About Our Speaker(s)

Will Woodlee | Food and Drug Law SpeakerWill Woodlee
Will Woodlee is a partner in the law firm of Kleinfeld, Kaplan, and Becker, LLP, in Washington, DC. His practice focuses primarily on counseling and advocating on behalf of food, dietary supplement, cosmetic, pharmaceutical, medical device, tobacco product, and consumer product companies on regulatory and advertising l... More info

 
Recommend this event to a colleague
  • Your Name:
  • Your E-mail:
  • Colleague's Name:
  • Colleague's E-mail:
  •  
    Subject: You might be interested in this event from AudioSolutionz
    Event Title: The Cannabidiol (CBD) Conundrum: Understanding the Ingredient's Legal and Regulatory Status
    Presenter(s): Will Woodlee

 
 
 
Our Accreditation Partners
DMCA.com Protection Status